International Journal of Cardiology Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial Jeremie Abtan, Gregory Ducrocq, Ph. Gabriel Steg, Gregg W. Stone, Kenneth W. Mahaffey, C. Michael Gibson, Christian Hamm, Matthew J. Price, Jayne Prats, Steven Elkin, Efthymios N. Deliargyris, Harvey D. White, Alberto Menozzi, Robert A. Harrington, Deepak L. Bhatt International Journal of Cardiology Volume 278, Pages 217-222 (March 2019) DOI: 10.1016/j.ijcard.2018.11.114 Copyright © 2018 The Authors Terms and Conditions
Fig. 1 Ischemic events at 48 h. International Journal of Cardiology 2019 278, 217-222DOI: (10.1016/j.ijcard.2018.11.114) Copyright © 2018 The Authors Terms and Conditions
Fig. 2 Bleeding events at 48 h. International Journal of Cardiology 2019 278, 217-222DOI: (10.1016/j.ijcard.2018.11.114) Copyright © 2018 The Authors Terms and Conditions